The increasing prevalence of lifestyle and chronic diseasespaired with growing acceptance of molecular diagnostics in personalized medicine, and growth in the number of private diagnostic centers are few of the factors responsible for the growth of global in vitro diagnostics market. The Global IVD market is valued at USD 60 billion in 2016 and is projected to surpass the value of 84 Billion by 2022 with CAGR of 5.7%. In addition to driving factors, new growth opportunities like untapped emerging regions will help this market grow further whereas increasing healthcare cost and lack of reimbursement in some regions will also show their impact on this market.
This report presents most of such influencing factors affecting market growth in detail. Along with that, this report also talks about industry trends and regulatory scenario in different geographic regions.
This research study involved the extensive usage of both primary and secondary data sources to build this market to such drill down segmentation level on the basis of product & services, technology, application, end user, and geographic region.
Global In Vitro Diagnostics Market, by Products and Services
- Reagents & Kits
- Data Management Software
Global In Vitro Diagnostics Market, by Technology
- Clinical Chemistry
- Basic Metabolic Panel
- Electrolyte Panel
- Liver Panel
- Lipid Profile
- Renal Profile
- Thyroid Function Panel
- Specialty Chemical Tests
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Chemiluminescence Immunoassay (CLIA)
- Fluorescence Immunoassay (FIA)
- Colorimetric Immunoassay (CI)
- Radioimmunoassays (RIA)
- Rapid Tests
- Western Blot
- Coagulation & Hemostasis
- Clinical Microbiology
- Molecular Diagnostics (MDx)
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- DNA Sequencing & Next-generation Sequencing
- Other MDx technologies
- Other Technologies
Global In Vitro Diagnostics Market, by Application
- Infectious Diseases
- Autoimmune Diseases
- Drug Testing
- Other Applications
Global In Vitro Diagnostics Market, by End User
- Academic Institutes
- Point-Of-Care Testing
- Patient Self-Testing
- Other End Users
Global In Vitro Diagnostics Market, by Region
- North America
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- Rest of Asia-Pacific (RoAPAC)
- Rest of the World
Competitive Intelligence is one more important section of this report which includes market share analysis and company profile of 13 key players operating in this market. The key players in this market are Roche Diagnostics (Switzerland), Abbott Laboratories (U.S.), Siemens Healthineers (Germany), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Sysmex Corporation (Japan), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux (France), and Becton, Dickinson and Company (U.S.), Johnson and Johnson (U.S.), Qiagen N.V. (Germany), Ortho-Clinical Diagnostics, Inc. (U.S.), and Diasorin S.P.A. (Italy).
Company profile section includes company introduction, product and/or services offered by company, its financials and related recent developments for last 3 years. (The financials and recent developments that is available in public domain will be included).
With the given market data, we also offers customizations as per the client’s specific needs. The following customization options are available for the report:
- Product matrix, which gives a detailed comparison of the product portfolios of each company
- Further breakdown of the Rest of Asia-Pacific in vitro diagnostics market in South Korea, Australia, New Zealand, and other countries
- Further breakdown of rest of the world into Latin America and Middle-East Africa.
- Detailed analysis and profiling of additional market players.